IL2 and neoplasm: Antigen-specific T cells isolated directly from tumour biopsies (tumour infiltrating lymphocytes (TILs)) are identified by observing their functional response against melanoma antigens and then subsequently expanded ex vivo by IL-2-driven expansion regimes (Dudley et al, 2002a).